TIGD6

gene
On this page

Also known as DKFZp761E2110

Summary

TIGD6 (tigger transposable element derived 6, HGNC:18332) is a protein-coding gene on chromosome 5q32, encoding Tigger transposable element-derived protein 6 (Q17RP2).

The protein encoded by this gene belongs to the tigger subfamily of the pogo superfamily of DNA-mediated transposons in humans. These proteins are related to DNA transposons found in fungi and nematodes, and more distantly to the Tc1 and mariner transposases. They are also very similar to the major mammalian centromere protein B.

Source: NCBI Gene 81789 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 96 total
  • Dosage sensitivity (ClinGen): haploinsufficiency dosage sensitivity unlikely, triplosensitivity no evidence
  • MANE Select transcript: NM_030953

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:18332
Approved symbolTIGD6
Nametigger transposable element derived 6
Location5q32
Locus typegene with protein product
StatusApproved
AliasesDKFZp761E2110
Ensembl geneENSG00000164296
Ensembl biotypeprotein_coding
Entrez81789

Gene structure

Transcript identifiers

Ensembl transcripts: 5 — 4 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000296736, ENST00000515406, ENST00000532987, ENST00000893998, ENST00000915769

RefSeq mRNA: 4 — MANE Select: NM_030953 NM_001243253, NM_001412170, NM_001412172, NM_030953

CCDS: CCDS4301

Canonical transcript exons

ENST00000296736 — 2 exons

ExonStartEnd
ENSE00001083170149993118149996429
ENSE00001211682150000474150000654

Expression profiles

Bgee: expression breadth ubiquitous, 179 present calls, max score 79.31.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.3731 / max 108.5483, expressed in 1727 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
641461.84541218
641471.67361140
641480.8541590

Top tissues by expression

273 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099179.31gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047378.13gold quality
islet of LangerhansUBERON:000000678.09gold quality
stromal cell of endometriumCL:000225577.88gold quality
buccal mucosa cellCL:000233677.64silver quality
right adrenal gland cortexUBERON:003582775.94gold quality
mucosa of transverse colonUBERON:000499175.92gold quality
left adrenal glandUBERON:000123475.91gold quality
right adrenal glandUBERON:000123375.89gold quality
left adrenal gland cortexUBERON:003582575.70gold quality
C1 segment of cervical spinal cordUBERON:000646975.63gold quality
rectumUBERON:000105274.91gold quality
adenohypophysisUBERON:000219674.55gold quality
calcaneal tendonUBERON:000370174.30gold quality
tibial nerveUBERON:000132374.25gold quality
hindlimb stylopod muscleUBERON:000425273.74gold quality
adrenal glandUBERON:000236973.39gold quality
adrenal cortexUBERON:000123573.29gold quality
transverse colonUBERON:000115773.09gold quality
ventricular zoneUBERON:000305372.73gold quality
olfactory segment of nasal mucosaUBERON:000538672.54gold quality
spinal cordUBERON:000224072.05gold quality
popliteal arteryUBERON:000225072.04gold quality
tibial arteryUBERON:000761072.03gold quality
lower esophagus muscularis layerUBERON:003583372.02gold quality
lower esophagusUBERON:001347372.01gold quality
left coronary arteryUBERON:000162671.88gold quality
pancreasUBERON:000126471.80gold quality
left ovaryUBERON:000211971.79gold quality
aortaUBERON:000094771.69gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no3.64

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

79 targeting TIGD6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6798-5P100.0065.77699
HSA-MIR-3163100.0077.238605
HSA-MIR-8485100.0077.574731
HSA-MIR-6870-5P99.9968.552115
HSA-MIR-477599.9875.006394
HSA-MIR-4723-5P99.9768.702034
HSA-MIR-569899.9768.492029
HSA-MIR-7111-5P99.9768.482062
HSA-MIR-495-3P99.9672.814197
HSA-MIR-568899.9673.234504
HSA-MIR-1250-3P99.9670.044038
HSA-MIR-568099.9169.833421
HSA-MIR-6780A-5P99.8866.692776
HSA-MIR-806299.8868.43995
HSA-MIR-30A-3P99.8769.742928
HSA-MIR-30D-3P99.8769.922917
HSA-MIR-30E-3P99.8769.682942
HSA-MIR-132399.8369.892471
HSA-MIR-442099.8270.081624
HSA-MIR-181B-2-3P99.8170.061646
HSA-MIR-181B-3P99.8170.061646
HSA-MIR-205299.7969.372031
HSA-MIR-1273H-5P99.7766.322471
HSA-MIR-129999.7771.242389
HSA-MIR-30B-3P99.7065.762325
HSA-MIR-3689A-3P99.7065.732306
HSA-MIR-3689B-3P99.7065.712311
HSA-MIR-3689C99.7065.712311
HSA-MIR-6779-5P99.7065.762363
HSA-MIR-128399.6972.423009

Functional genomics

ClinGen dosage: haploinsufficiency 40 (dosage sensitivity unlikely), triplosensitivity 0 (no evidence). ClinGen Gene Dosage Map

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_rerioENSDARG00000099590
danio_rerioENSDARG00000101994
danio_rerioENSDARG00000103972

Paralogs (12): CENPB (ENSG00000125817), TIGD7 (ENSG00000140993), POGK (ENSG00000143157), POGZ (ENSG00000143442), TIGD4 (ENSG00000169989), TIGD3 (ENSG00000173825), TIGD5 (ENSG00000179886), TIGD2 (ENSG00000180346), JRKL (ENSG00000183340), TIGD1 (ENSG00000221944), JRK (ENSG00000234616), (ENSG00000293642)

Protein

Protein identifiers

Tigger transposable element-derived protein 6Q17RP2 (reviewed: Q17RP2)

All UniProt accessions (1): Q17RP2

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Nucleus.

Similarity. Belongs to the tigger transposable element derived protein family.

RefSeq proteins (4): NP_001230182, NP_001399099, NP_001399101, NP_112215* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR004875DDE_SF_endonuclease_domDomain
IPR006600HTH_CenpB_DNA-bd_domDomain
IPR007889HTH_PsqDomain
IPR009057Homeodomain-like_sfHomologous_superfamily
IPR050863CenT-Element_DerivedFamily

Pfam: PF03184, PF03221, PF04218

UniProt features (9 total): domain 3, DNA-binding region 2, sequence variant 2, chain 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q17RP2-F177.190.29

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 58 (showing top): PAX4_01, GOZGIT_ESR1_TARGETS_DN, ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN, NRF2_01, CETS1P54_01, AP2GAMMA_01, chr5q32, YGCGYRCGC_UNKNOWN, SCGGAAGY_ELK1_02, AP2ALPHA_01, ELK1_02, ZWANG_DOWN_BY_2ND_EGF_PULSE, KRAS.600.LUNG.BREAST_UP.V1_UP, CHAF1B_TARGET_GENES, CREB3L4_TARGET_GENES

GO Biological Process (0):

GO Molecular Function (2): DNA binding (GO:0003677), nucleic acid binding (GO:0003676)

GO Cellular Component (1): nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
nucleic acid binding1
binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

472 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TIGD6OR52N4Q8NGI2474
TIGD6ALG1L2C9J202470
TIGD6ZNF681Q96N22446
TIGD6CENPBD1PB2RD01439
TIGD6NAIF1Q69YI7439
TIGD6ZNF648Q5T619432
TIGD6HMGXB3Q12766413
TIGD6FOXD4Q12950395
TIGD6ZNF596Q8TC21370
TIGD6HARBI1Q96MB7370
TIGD6TMEM169Q96HH4369
TIGD6TIGD5Q53EQ6365
TIGD6SLC35D4Q24JQ0359
TIGD6A0A087WTP8A0A087WTP8358
TIGD6GDPD4Q6W3E5348
TIGD6B3GNT4Q9C0J1348

IntAct

4 interactions, top by confidence:

ABTypeScore
TIGD6MTHFRpsi-mi:“MI:0914”(association)0.530
TIGD6ZRANB2psi-mi:“MI:0914”(association)0.350

BioGRID (25): ABCF1 (Affinity Capture-MS), ACSL3 (Affinity Capture-MS), MAPT (Affinity Capture-MS), UBE2V2 (Affinity Capture-MS), TAGLN2 (Affinity Capture-MS), MTA1 (Affinity Capture-MS), ZRANB2 (Affinity Capture-MS), SRA1 (Affinity Capture-MS), CHAF1A (Affinity Capture-MS), MAGED2 (Affinity Capture-MS), MRPL13 (Affinity Capture-MS), SS18L2 (Affinity Capture-MS), NUP54 (Affinity Capture-MS), DYNC2H1 (Affinity Capture-MS), SNX27 (Affinity Capture-MS)

ESM2 similar proteins: A4IFA3, A4Z943, A4Z944, A4Z945, B2RRL2, D3Z4R1, F1NQJ3, O43422, O60108, O60290, O96006, P08770, P0CF97, P12258, P16320, P34601, Q09772, Q0VBL1, Q17RP2, Q3EBC8, Q3YK19, Q49AG3, Q4R6P1, Q4W5G0, Q5SVZ6, Q5SXJ3, Q6EKJ0, Q6NT04, Q6R2W3, Q7L775, Q7M3K2, Q86UP8, Q8BUZ3, Q8IY51, Q8IZ13, Q8TBB0, Q8TCP9, Q8TDG4, Q8VEH5, Q95M72

Diamond homologs: P07199, P27790, P48988, P49451, Q17RP2, Q4W5G0, Q6B0B8, Q8IY51, Q8BUZ3, Q6NT04, B2RRL2, O75564, Q0VBL1, Q60976, Q96MW7, Q9Y4A0, Q7TM95

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

96 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance88
Likely benign2
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

281 predictions. Top by Δscore:

VariantEffectΔscore
5:149996428:AG:Aacceptor_gain0.9900
5:149996430:C:CCacceptor_gain0.9900
5:149996427:AAG:Aacceptor_gain0.9800
5:149996428:AGCTG:Aacceptor_loss0.9800
5:149996430:CT:Cacceptor_loss0.9800
5:149996431:T:Gacceptor_loss0.9800
5:149999927:CAGTG:Cdonor_gain0.9700
5:150000587:A:ACdonor_gain0.9700
5:150000588:C:CCdonor_gain0.9700
5:149996425:GAAAG:Gacceptor_gain0.9600
5:149996426:AAAG:Aacceptor_gain0.9600
5:150000541:T:TAdonor_gain0.9600
5:149999926:A:ACdonor_gain0.9500
5:149999927:C:CCdonor_gain0.9500
5:149996440:A:Tacceptor_loss0.9300
5:150000216:C:CTdonor_gain0.9300
5:150000217:T:TTdonor_gain0.9300
5:149999927:CA:Cdonor_gain0.9100
5:149999991:C:CTdonor_gain0.9100
5:149999992:T:TTdonor_gain0.9100
5:150000213:TCAC:Tdonor_gain0.9100
5:150000468:TGTTA:Tdonor_loss0.9100
5:150000469:GTTAC:Gdonor_loss0.9100
5:150000470:TTACC:Tdonor_loss0.9100
5:150000471:TAC:Tdonor_loss0.9100
5:150000473:CCTGA:Cdonor_loss0.9100
5:150000474:C:Adonor_loss0.9000
5:150000631:C:CAdonor_gain0.8900
5:149999927:CAGT:Cdonor_gain0.8800
5:150000588:CTAGA:Cdonor_gain0.8800

AlphaMissense

3490 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
5:149996238:A:CF37L0.966
5:149996238:A:TF37L0.966
5:149996240:A:GF37L0.966
5:149995968:A:CF127L0.962
5:149995968:A:TF127L0.962
5:149995970:A:GF127L0.962
5:149995998:A:CF117L0.962
5:149995998:A:TF117L0.962
5:149996000:A:GF117L0.962
5:149995982:A:GW123R0.959
5:149995982:A:TW123R0.959
5:149995821:A:CF176L0.946
5:149995821:A:TF176L0.946
5:149995823:A:GF176L0.946
5:149996313:G:CF12L0.931
5:149996313:G:TF12L0.931
5:149996315:A:GF12L0.931
5:149996218:A:GL44S0.918
5:149996233:A:GI39T0.916
5:149996282:C:GA23P0.912
5:149995960:C:GR130P0.911
5:149995969:A:GF127S0.910
5:149995794:G:CF185L0.907
5:149995794:G:TF185L0.907
5:149995796:A:GF185L0.907
5:149996091:A:CF86L0.907
5:149996091:A:TF86L0.907
5:149996093:A:GF86L0.907
5:149996233:A:CI39S0.906
5:149995089:A:CF420L0.904

dbSNP variants (sampled 300 via entrez): RS1000118570 (5:149999404 T>C), RS1000188063 (5:150000665 G>A), RS1000679417 (5:150000241 G>A), RS1000980030 (5:150000466 C>T), RS1001527020 (5:149995415 G>A), RS1001790575 (5:149997946 G>A), RS1002016821 (5:149995497 G>A), RS1002103904 (5:150000673 A>C,G), RS1002127915 (5:149996614 GATCTT>G), RS1002677824 (5:150000725 C>T), RS1002704710 (5:149995722 C>A,T), RS10036377 (5:149994453 A>G), RS1003745606 (5:150002195 T>C), RS1003812758 (5:150001020 C>G,T), RS1003907917 (5:150000717 C>A,T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST90002396_313Mean reticulocyte volume2.000000e-11

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0010701mean reticulocyte volume

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

23 total (human), top 23 by PubMed support.

ChemicalActions (top 5)PubMed papers
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
GSK-J4decreases expression1
bisphenol Faffects cotreatment, increases expression1
TAK-243increases sumoylation1
triphenyl phosphateaffects expression1
bisphenol Aaffects cotreatment, increases expression1
sodium arseniteincreases expression1
butyraldehydedecreases expression1
ferrous chloridedecreases expression1
pentanaldecreases expression1
perfluoro-n-nonanoic acidincreases expression1
abrineincreases expression1
Sunitinibincreases expression1
Amiodaroneincreases expression1
Dexamethasoneaffects cotreatment, increases expression1
Indomethacinaffects cotreatment, increases expression1
Potassium Chloridedecreases response to substance, decreases expression1
Smokedecreases expression1
Dronabinoldecreases response to substance, decreases expression1
Triiodothyronineincreases expression1
Urethaneincreases expression1
1-Methyl-3-isobutylxanthineaffects cotreatment, increases expression1
Cadmium Chloridedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.